- Author:
Haechan CHO
1
;
Jeehoon KANG
;
Hyo-Soo KIM
;
Kyung Woo PARK
Author Information
- Publication Type:Review Article
- From:Korean Circulation Journal 2020;50(8):645-657
- CountryRepublic of Korea
- Abstract: Oral antithrombotic therapy (antiplatelet therapy and anticoagulation therapy) is a key element of pharmacotherapy in patients with cardiovascular (CV) disease. Several reports of ethnic differences have suggested that there may be difference therapeutic requirements and response to therapy for antithrombotic therapy. In particular for East Asians, there seems to be a lower incidence of ischemic outcomes and a higher incidence of bleeding outcomes compared to Westerners. The purpose of this review is to describe the ethnicity-related differences in antithrombotic therapy for CV disease and to discuss the need to establish a more effective and targeted antithrombotic treatment strategy in East Asians.